Jasper Therapeutics, Inc. (JSPR)
0.51
+0.01
(+2.91%)
USD |
NASDAQ |
Oct 23, 16:00
0.52
+0.01
(+1.96%)
After-Hours: 20:00
Jasper Therapeutics EPS Diluted (Quarterly) : -0.0962 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0962 |
| March 31, 2026 | -0.041 |
| December 31, 2025 | -0.3175 |
| September 30, 2025 | -1.126 |
| June 30, 2025 | -1.743 |
| March 31, 2025 | -1.414 |
| December 31, 2024 | -1.620 |
| September 30, 2024 | -1.242 |
| June 30, 2024 | -0.9731 |
| March 31, 2024 | -1.030 |
| December 31, 2023 | -1.501 |
| September 30, 2023 | -1.599 |
| June 30, 2023 | -1.472 |
| March 31, 2023 | -1.618 |
| Date | Value |
|---|---|
| December 31, 2022 | -3.604 |
| September 30, 2022 | -3.244 |
| June 30, 2022 | -2.858 |
| March 31, 2022 | -0.6078 |
| December 31, 2021 | -2.392 |
| September 30, 2021 | -6.870 |
| June 30, 2021 | -39.97 |
| March 31, 2021 | -49.24 |
| December 31, 2020 | -36.04 |
| September 30, 2020 | -61.41 |
| June 30, 2020 | -2.746 |
| March 31, 2020 | 1.143 |
| September 30, 2019 | -0.0008 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.76M |
| Total Expenses (Quarterly) | 2.76M |
| Enterprise Value | 6.860M |
| Earnings Yield | -310.0% |
| Normalized Earnings Yield | -407.16 |